EP 32 | AXA Stock Analysis: Is This Dividend Giant Ready to Soar? Published: 2026-10-27T19:21:03Z Reviewed: 2026-10-27T19:07:36.205156+00:00 Codex AI parent read all300selectedsegments, all1357segments across4whole takes and all328finaltoken-timedEnglishcaptioncues; primary and governed checks independent of upstreammanual/source-displayQA which remainsOPEN. Selected wholeV04noeditorialcuts/joins/padding/speedchanges; fullMP3/MP4decodes,6actual1080frames and3reduced320chartframes passed. No human/fulluninterruptedlistening/perfectauralclaim; phonetic/name/display and float-capital/insurance-premium/accounting compression/instruction-like phrase/event-scope limits retained in final-qa.json. Actual ordinaryRSS full decoded correlation0.9998463685382134 with zero lag establishes platform-transcode correspondence, not byteidentity or humanlistening. [0:00] So how can a massive global insurer report rising earnings per share while [0:05] its total overall profit barely grows at all? [0:08] Yeah, it's a huge red flag if you aren't paying attention. [0:11] Right. [0:12] Welcome to AI Investment Edge, episode 32. [0:15] If you're holding financial stocks or just looking for where the market is completely [0:19] mispricing value, [0:21] this is exactly the kind of puzzle you need to figure out. [0:25] Because there's a core distinction you have to keep in mind, right? [0:27] Profit is just an accrual-based accounting metric. [0:31] Exactly. Whereas cash flow measures the actual cash movements. [0:35] So just because an insurer's profit looks flat or maybe slightly rising, that doesn't [0:40] mean their cash is doing the same thing. [0:43] Right. Because sometimes, you know, rising earnings per share just reflects aggressive [0:46] share repurchases. [0:47] Which forces us to ask, what's the actual underlying quality of the remaining [0:52] business? [0:54] So today, we're going to synthesize 14 different AI-generated financial [0:57] frameworks, analyst targets, and current market data for a deep dive into [1:03] AXA. [1:04] Before we really get into the mechanics of their earnings, I should establish the [1:07] public evidence-weighted consensus. [1:09] Yeah. Let's get that out of the way early. [1:11] So checked October 27th on the October 26th close, 42.33 [1:16] euros. [1:17] The consensus is a strong buy at the one-year horizon and a buy at the five-year [1:21] horizon. [1:23] And for anyone tracking the platform research ratings, we need to be really [1:27] clear. [1:28] You have to keep the immediate strong buy and keep for dividends label entirely [1:31] distinct from those horizon ratings. [1:34] Oh, absolutely. [1:35] I mean, those are platform research ratings, right? [1:37] They're not mathematical promises of a soaring stock price. [1:40] Yeah. And they're separate from individual opinions or like the all-advisor average. [1:45] But let's frame up what you're actually buying with AXA. [1:48] It's a France-based global insurer serving households and businesses. [1:52] And when people hear insurance, they usually just think car crashes or house [1:56] fires. [1:56] Right. But we explicitly need to include life and health insurance. [2:00] And employee protection cover is major parts of their business. [2:04] That's alongside the motor, home, commercial property, and liability stuff. [2:09] Yeah. Plus AXA XL, which handles the really large commercial and specialty risks. [2:14] So structurally, they collect premiums to accept those risks. [2:17] Right. And then the investment income they generate on the assets backing those [2:20] promises, well, that [2:22] supplies a completely distinct earnings stream from the underwriting itself. [2:25] Which actually reminds me of our previous deep dive on Ping An. [2:29] We talked about how you absolutely must examine an insurer's obligations, its [2:32] investment returns, [2:34] and the parent company's cash entirely separately. [2:37] Yeah. You can't look at an insurer's balance sheet like it's a software company. [2:41] Definitely not. Which brings up this idea of insurance float. [2:45] You know, the premiums held before claims are paid. [2:47] I feel like there's this big misconception that float is just free shareholder money. [2:52] Oh, it is absolutely not free shareholder money. [2:54] That float is highly regulated capital, strictly backing future liabilities. [2:58] Right. And on the asset side, you should know AXA actually sold its asset management [3:02] business, [3:03] AXA IM, to BNP Paribas on July 1st, 2025. [3:07] So they still invest their own insurance assets, but they don't own that fee [3:10] management business [3:11] anymore. Exactly. [3:12] Okay. That sets the table perfectly. [3:14] Now let's move straight from the business model into the mathematical reality of [3:17] their performance. [3:18] We have four key financial findings, starting with earnings. [3:22] Yeah. This is where that initial puzzle comes from. [3:24] So H1 group underlying profit was about 4.5 billion euros. [3:28] Which is what, up only 2% on a reported basis? [3:31] Right. Up 2% reported. [3:33] Yet underlying earnings per share rose 8% to 2.19 euros. [3:39] Because their diluted shares fell about 6%? [3:41] Exactly. [3:42] You know, we usually try to avoid the classic pizza analogy for share buybacks [3:45] because it [3:46] feels a bit basic. [3:47] But here is actually the perfect warning. [3:49] Yeah, it really is. [3:50] Buybacks are literally dividing a pizza into fewer slices. [3:54] You retire shares, so every remaining slice, the EPS, is mathematically larger. [3:59] But they haven't actually baked a larger pizza. [4:02] Right. The organic growth of the profit pool hasn't suddenly exploded by 8%. [4:06] That's just denominator shrinkage. [4:08] And EPS growth alone does not measure organic business growth. [4:12] Definitely not. [4:13] Plus, you have to look at the different bases they use. [4:15] Like, on a constant currency basis, underlying earnings rose 4%. [4:20] Or, if you exclude the sold AXA IM business completely, it rose [4:25] 9%. [4:25] Wow. Okay. [4:27] So those are three completely different bases, not just three ways of describing [4:31] the same growth rate. [4:32] Exactly. You have to read the reports carefully. [4:35] So let's connect that modest 2% profit growth to our second finding, which is [4:39] profitability. [4:40] How much are they actually making on the insurance side? [4:43] Well, in H1, the property and casualty all year combined ratio was 90.1% [4:49] compared to 90.0% last year. [4:52] Okay. [4:52] Meaning for every euro of premium they take in, they pay out about 90 cents in claims [4:58] and expenses. [4:59] Yeah, but an aggregate number that flat usually hides some internal friction. [5:04] Always does. [5:05] But it's underneath it. [5:06] Personal lines actually improved, dropping from 93.3% to 91.5%. [5:11] But commercial lines worsened from 89.9% up to [5:15] 90.9%. [5:17] Okay. But how do interest rates factor into that ratio? [5:20] That's the crucial implication here. [5:22] Higher interest rates increase the discounting of future claims, which [5:25] mathematically improved [5:27] the reported ratio by 0.2 points. [5:29] I want to pause on that mechanism because it's vital. [5:33] Discounting future claims improves the reported ratio on paper because of the time [5:38] value of money, right? [5:39] Yes. [5:40] Higher rates mean the cash they hold today will grow more by the time they pay out. [5:43] Right. It's an underwriting measure. [5:45] Exactly. [5:45] It does not mean the physical claims like the car crashes suddenly vanished. [5:49] Exactly. [5:49] And while strong retail pricing offsets the commercial weakness right now, one benign [5:55] half year doesn't prove permanent pricing power. [5:57] Fair point. Which brings us to the third finding, the balance sheet. [6:01] Right. Solvency II was 218% at June 30. [6:04] That's their capital versus the model requirement. [6:07] And keep in mind, a January transition reset their starting ratio to 215%. [6:12] So that capital buffers their underwriting and investment risks. [6:16] But the 454 billion euro invested asset portfolio, that's a completely separate [6:21] figure, right? [6:22] Entirely separate, yeah. [6:23] So if they're sitting at 218%, they clearly have excess capital over the minimum. [6:28] But does that mean they can just, you know, sweep all that cash into a special [6:31] dividend? [6:32] No, absolutely not. [6:33] Excess capital over the minimum is not automatically distributable. [6:37] Assets and liabilities are managed together. [6:39] Right. So think about a sovereign credit shock. [6:43] If government bond spreads widen, the value of the bonds AXA holds drops. [6:48] That hurts their capital position today. [6:50] Even though those higher yields will improve future reinvestment down the line. [6:54] Exactly. [6:54] The same force has opposite effects on today's asset values and tomorrow's [6:58] coupons. [6:59] Which leads us perfectly into the fourth finding, investment and the spoken cash [7:03] bridge. [7:04] Let's look at their tech investments. [7:06] Well, H1 physical and intangible purchases were only 174 million euros. [7:11] But AI is projected to generate 500 to 700 million euros of recurring pre-tax [7:16] value by 2029. [7:18] And that's net of investment across growth and efficiency. [7:21] It's not just banked savings. [7:23] Right. [7:23] But that low 174 million figure for physical purchases trips people up. [7:28] Yeah. I mean, compare it to our deep dive on Amazon. [7:31] Amazon's investment constraint is visible. [7:33] You can literally drive past a massive data center. [7:36] But an insurer's constraint is regulatory capital. [7:40] It is. Which is why we need to clearly map out the cash bridge. [7:43] Let me speak the exact math here. [7:45] Let's hear it. [7:46] So H1 operating inflow was about 8 billion euros down from about 15 billion [7:51] last year. [7:52] Mostly due to larger receivable, payable and other balance movements. [7:57] Okay. 8 billion operating. [7:59] Right. About 8 billion operating minus 4 billion investing minus 8 [8:05] billion financing plus 1 billion currency. [8:08] That means cash falls from about 21 billion down to 18 billion. [8:14] That's a perfect illustration that cash flow from operations minus small capex is [8:19] not unrestricted shareholder free cash flow. [8:21] Not at all. It's like regulated reservoirs. [8:24] The regulated subsidiaries are separate reservoirs. [8:27] Just because there's water in a regional reservoir doesn't mean it's automatically [8:30] at the parent company's tap in Paris. [8:32] Yes. Consolidated cash and subsidiary remittance are totally different things. [8:37] So that 25 billion euro cumulative 2027 to 2029 upstream target, [8:42] that's before holding costs and interest. [8:46] It's not an annual free cash flow and definitely not a promised payout. [8:51] Exactly. [8:52] So how does all this translate to valuation? [8:54] If we use that separately dated October 27th 42.46 euro Euronext trade, [8:59] that's roughly 11 times their actual reported FY 2025 underlying EPS of 3.86 [9:05] euros. [9:06] Right. A completed historical year. [9:08] But FY 2025 net income was 9.8 billion euros and that included the AXA IM sale [9:13] gain. Oh, so you can't count that as recurring. [9:16] No, don't count it as recurring. [9:18] Got it. [9:19] Let's look at the fixed base, the bull, the bear, and the dividend cash based on that [9:23] 42.46 euro trade. [9:24] What are the targets? [9:26] Well, the fixed targets for the third quarter of 2027 are about 49 euros. [9:30] For the third quarter of 2031, it's about 65 euros. [9:34] So that's cumulative price returns of about 14% and 52%? [9:39] Yeah. But you have to factor in the dividend cash. [9:42] The annual ordinary dividend is about 2.3 euros, excluding the already paid May 2026 [9:47] one. Right. [9:48] Assuming flat future May payments. [9:51] One payment by 2027 gives about 2.3 euros gross cash. [9:55] And five payments by 2031 gives about 11.6 euros gross cash. [10:00] Which yields about 19.8% and just under 80% cumulative cash [10:05] inclusive returns. [10:07] That's before tax and fees. [10:08] No reinvestment assumed. [10:10] Right. [10:10] And just clarify, the public net yield reinvestment rating differs from that. [10:15] Okay. So what pushes this into a bull or bear scenario? [10:18] Well, first, strictly define investment carry as income after relevant funding or [10:22] guarantee costs. [10:23] It's separate from underwriting. [10:24] Okay. [10:25] The bull case is profitable growth, useful carry, compounding without multiple [10:30] expansion. [10:31] The bear case is commercial softness, reserve strengthening, and investment [10:35] losses. [10:36] And to be clear, there are no invented, synthesized bull or bear endpoints or [10:40] probabilities here. [10:42] And absolutely no guaranteed buyback floors. [10:44] No. None. [10:46] Let's talk about the four quadrants with those upside and downside tails. [10:49] What's normal? [10:50] Normal quadrants are renewing low coupon bonds at higher yields, resilient retail [10:55] demand versus soft commercial pricing, expensive repairs, and capital sensitivity [11:00] to bond spreads. [11:01] It's basically a moving walkway analogy, right? [11:04] The gradual bond rollover gives you this continuing lift as old bonds mature into [11:09] higher yields. [11:10] But claims inflation is moving against you. [11:13] That's a great way to picture it. [11:15] So what's the upside tail? [11:17] Stronger capital generation plus AI underwriting. [11:20] But a vital correction here. [11:22] The expected 17-point Solvency II uplift in Q1-2027 is already disclosed based on [11:27] January conditions. [11:28] So it's not new earnings or some announced special buyback windfall. [11:33] Right. It's already known. [11:34] As for the downside tail, that would be a cluster of catastrophes hitting alongside a [11:39] sovereign credit or casualty reserve shock. [11:42] Wait, let me push back a bit. [11:44] AXA is huge. [11:45] They have a 218% solvency ratio. [11:48] Doesn't that scale essentially put a floor on the stock price? [11:52] No, it firmly does not. [11:55] Neither scale nor that ratio creates a price floor. [11:58] Under severe stress, a buyback pause or a dividend cut is definitely possible. [12:03] Right, because parent dividends depend on liquidity, costs, and board decisions to [12:07] protect solvency. [12:09] Exactly. [12:10] Which brings us to the alpha gap. [12:11] The hypothesis is that investors overlook this steady per-share compounding because, [12:16] you know, European insurance looks dull. [12:18] Right, but the counter-argument is that the discount might correctly price in that [12:22] commercial softness and sovereign risk. [12:25] And this is where the advisor disagreement comes in. [12:27] We should explicitly state that all 14 contributions are AI-generated. [12:32] Yes. [12:33] They span nine frameworks and three model versions, with 12 using the same Gemini [12:37] version, showing correlated AI perspectives. [12:40] So what's the core disagreement between the AI frameworks? [12:43] It's about whether AXA needs multiple expansion or if earnings and dividend [12:47] compounding is enough. [12:50] Why do they disagree? [12:51] Some of the overly optimistic models mistook the sale gains for recurring [12:55] earnings. [12:56] The stronger forensic AI models corrected this. [12:59] Ah, which is why the current ratings remain distinct from the original September Buy [13:02] Buy labels. [13:04] Exactly. Let's map out the quarterly path. [13:06] The 20-quarter path rises to about 46 euros in Q4 2026 and about [13:12] 47 euros in Q1 2027. [13:14] But investors have to watch for modeled spring ex-dividend dips. [13:18] Explain that mechanism. [13:19] Sure. All else equal, the price reference adjusts down when the dividend entitlement [13:24] detaches. [13:25] The cash is paid later. [13:26] And of course, actual market trades can move differently. [13:29] Right. [13:29] And as for actual events, the September 15th investor day already happened. [13:34] The October 29 indicators remain in the future. [13:37] And those only test premiums, not full year earnings. [13:40] Yeah. And note that we use event local time only. [13:44] No production Dubai conversions. [13:46] So how did the thesis change from July to September? [13:48] Well, July emphasized the cash harvest and cheap multiples. [13:53] But September challenged the distorted valuations and soft commercial markets. [13:58] And there was an actual strategy change on September 15th, right? [14:01] AXA raised their underlying EPS growth ambitions from 6% to 8% to 7% to 9% for [14:06] 2027 to 2029. [14:09] Yes, though those are targets, not achieved growth. [14:12] And the AXA IM sale closing in July 2025 was already in July's story. [14:17] Which brings up our last public stock baseline, Adyen from episode 31. [14:21] Oh, that's a good comparison. [14:22] Yeah. [14:23] I mean, Adyen's merchant settlement money and an insurer's policy obligations are [14:26] very different. [14:28] But both warn you against treating every reported cash euro as shareholder property. [14:33] Perfectly said. [14:34] So how does this thesis get invalidated? [14:38] The bear challenge is if commercial rate cuts outpace claims trends or casualty [14:43] reserves need strengthening or cash remittances disappoint while the board [14:47] protects solvency. [14:48] Right. [14:49] Because rising EPS driven mainly by a shrinking denominator like the buybacks is [14:54] way less persuasive if group profit stagnates. [14:57] But on the flip side, the bull challenge is that the pessimistic case fails if [15:01] technical margins and remittances hold through a soft cycle, [15:05] while investment carry and AI productivity accrue. [15:07] You really have to watch what is left after claims and capital retention. [15:12] Okay, let's synthesize this. [15:14] AXA could reward patient owners through recurring earnings in cash, but only if [15:18] underwriting quality holds. [15:20] We reiterate the strong buy 1Y and buy 5Y ratings. [15:26] The opportunity is disciplined compounding, not a guaranteed launch. [15:30] Exactly. We invite you to explore AXA's AI consensus, AI opinions, and profile and [15:36] fundamentals on iPulse AI. [15:38] Please like, comment, and subscribe. [15:40] We are publishing a new podcast every day of the week except Thursday. [15:45] Stay tuned for the next podcast on BNP Paribas. [15:48] Oh, BNP Paribas. [15:50] That connects right back to the AXA IM sale. [15:53] It does. Actually, just a quick curiosity hook before we go. [15:57] How exactly does BNP earn fees from that acquired asset management business? [16:03] Basically, client assets under management, or AUM, are managed strictly for fees. [16:08] Those are not automatically assets owned on BNP's balance sheet. [16:12] So it's not bank-owned money. [16:14] Always comes back to the regulated reservoirs, doesn't it? [16:17] See you next time.